新型有源骨传导听力植入体BCI 602的早期结果:系统综述与Meta分析
本系统综述与Meta分析遵循PRISMA指南,从108篇文献中纳入6篇(5.6%),评估成人与儿童混合性或传导性听力损失患者植入BCI 602的早期听力学与医学结果,共116例患者(成人64例,儿童52例)。Meta分析显示,助听条件下声场阈值、信噪比和言语识别率较未助听条件均有显著改善。
要点
- BCI 602植入术后并发症少,成人与儿童听力学结果均优良。
- Meta分析显示助听条件下声场阈值、信噪比和言语识别率显著优于未助听条件。
- 作者认为BCI 602具有较高安全性和可靠性,建议进一步与其他BCI直接比较及长期功能结局研究。
核心结论
- BCI 602植入与极少的 surgical 并发症相关,成人与儿童队列均获得优良的听力学结果。
- 本分析表明BCI 602具有较高水平的安全性和可靠性。
- 进一步研究应聚焦于与其他骨传导植入体的直接比较及长期功能结局。
研究设计与样本
- 遵循PRISMA指南的系统综述与Meta分析,共审查108篇文献,纳入6篇(5.6%)进入Meta分析。
- 共评估116例患者,其中成人64例(55%),儿童52例(45%)。
- 采用固定效应模型和随机效应模型分析术前与术后性能的平均差异(MD)。
主要发现
- 术中不良事件未见报告;术后并发症报告于2例(3.1%)成人患者和2例(3.8%)儿童患者。
- 研究一致显示助听条件下听力学结果、生活质量和声源定位均有显著改善。
- 声场阈值:助听条件较未助听条件MD为-27.05 dB(n=112;P<0.01)。
- 信噪比:助听条件较未助听条件MD为-6.35 dB(n=96;P<0.01)。
- 言语识别率:助听条件较未助听条件MD为68.89%(n=96;P<0.01)。
关键数值与推荐
- 声场阈值助听 vs 未助听:MD -27.05 dB(n=112;P<0.01)。
- 信噪比助听 vs 未助听:MD -6.35 dB(n=96;P<0.01)。
- 言语识别率助听 vs 未助听:MD 68.89%(n=96;P<0.01)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文指出当前研究患者数量有限,限制了统计效能和普遍性。
- 原文结论提出进一步研究应聚焦于与其他骨传导植入体的直接比较及长期功能结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The bone conduction implant (BCI) 602 is a new transcutaneous BCI with smaller dimensions. However, limited patient numbers restrict the statistical power and generalizability of the current studies. The present systematic review and meta-analysis summarize early audiological and medical outcomes of adult and pediatric patients implanted with the BCI 602 due to mixed or conductive hearing loss. DATA SOURCE: Following the Preferred Reporting items for Systematic Reviews and Meta-analyses guidelines, 108 studies were reviewed, and 6 (5.6%) were included in the meta-analysis. REVIEW METHOD: The data on study and patient characteristics, surgical outcomes, and audiological test results were extracted from each article. Meta-analysis employed the fixed-effect and random-effects models to analyze the mean differences (MDs) between pre- and postoperative performances. RESULTS: In total, 116 patients were evaluated, including 64 (55%) adult and 52 (45%) pediatric patients. No intraoperative adverse events were reported, while postoperative complications were reported in 2 (3.1%) adult and 2 (3.8%) pediatric patients. Studies consistently showed significant improvements in audiological outcomes, quality of life, and sound localization in the aided condition. In the meta-analysis, we observed a significant difference in the unaided compared to the aided condition in sound field thresholds (n = 112; MD, -27.05 dB; P < 0.01), signal-to-noise ratio (n = 96; MD, -6.35 dB; P < 0.01), and word recognition scores (n = 96; MD, 68.89%; P < 0.01). CONCLUSION: The implantation of the BCI 602 was associated with minimal surgical complications and excellent audiological outcomes for both the pediatric and the adult cohort. Therefore, our analysis indicates a high level of safety and reliability. Further research should focus on direct comparisons with other BCIs and long-term functional outcomes.
引用
- Lein A, Baumgartner WD, Riss D, et al. Early Results With the New Active Bone-Conduction Hearing Implant: A Systematic Review and Meta-Analysis. Otolaryngol Head Neck Surg. 2024. PMID: 38529662. doi:10.1002/ohn.728
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。